Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer

Recruiting now · Not applicable

Conditions studied: Lung Cancer

In brief

This study aims to address the challenge of predicting the efficacy of targeted and immunotherapy in lung cancer patients. By utilizing two DCE-MRI images-one before treatment and one after one treatment cycle-along with the patients' clinical and pathological information, we aim to achieve accurate prediction of the therapeutic efficacy of targeted and immunotherapy in lung cancer patients.

Key facts

Study ID

NCT06742021

Run by

Yunnan Cancer Hospital

People needed

195

Starts

2024-11-11

Expected to finish

2026-07-31

Last updated by the study team

2024-12-19

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Tumor size greater than 2 cm
• Age between 18 and 75 years

You may not qualify if…

• Presence of MRI contraindications (e.g., metal implants, pacemaker implantation, etc.)
• Allergy to gadolinium contrast agents
• Lesions difficult to delineate on images due to conditions such as atelectasis or diffuse lesions

Where it is running

• Yunnan Cancer Hospital — Kunming, Yunnan, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.